CCI dismisses case of alleged cartelisation by 2 bidders in AIIMS tender

CCI has dismissed a case of alleged cartelisation by Romsons Scientific & Surgical Industrial Pvt Ltd and BSN Medical Pvt Ltd

cci, competition commission of india
Competition Commission of India (CCI)
Press Trust of India New Delhi
2 min read Last Updated : Jan 18 2021 | 5:47 PM IST

The Competition Commission of India (CCI) has dismissed a case of alleged cartelisation by Romsons Scientific & Surgical Industrial Pvt Ltd and BSN Medical Pvt Ltd and some of their officials.

The regulator had directed the director general (DG) to carry out an investigation after the matter originated from a complaint alleging cartelisation by the firms in respect of a tender invited by AIIMS in 2016.

The DG after taking into consideration the submissions of the parties, concluded that different parties, at different geographical locations with different cost of production and profit margins quoting identical rates, independently, would be too much of coincidence, which is difficult to believe.

Accordingly, the DG concluded that the firms colluded and acted in contravention of provisions of the Competition Act.

However, the CCI said that there is no evidence of any communications or meetings having taken place between the opposite parties (OPs) or any other arrangement indicating a tacit collusion in respect of fixing the prices for the bids.

Apart from the present instance of identical pricing during the period under consideration, the investigation report falls short of providing clarity as to how such pricing was an outcome of collusion.

"There is lack of material to show any collusion on part of the OPs and the Commission, thus, concludes that it is not established that OP-1 and OP-2 have acted in contravention of the provisions of ...of the Act," the regulator said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CCICartel casecompetition law

First Published: Jan 18 2021 | 5:41 PM IST

Next Story